Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N Engl J Med. 2012 Oct 18; 367(16):1519-28.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Crohn Disease
Double-Blind Method
Drug Resistance
Female
Humans
Induction Chemotherapy
Maintenance Chemotherapy
Male
Middle Aged
Remission Induction
Severity of Illness Index
Ustekinumab
authors with profiles
Stephen B. Hanauer